• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine (CAS No. 1153040-15-3): An Overview of a Promising Compound in Medicinal Chemistry

1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine (CAS No. 1153040-15-3) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its potential therapeutic applications. This compound belongs to the class of pyrazoles, which are known for their diverse biological activities, including anti-inflammatory, antiviral, and anticancer properties. In this article, we will delve into the chemical structure, synthesis methods, biological activities, and recent research advancements related to 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine.

Chemical Structure and Properties

The chemical structure of 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine is characterized by a pyrazole ring substituted with a 3,4-dichlorophenyl group at the 1-position and an amino group at the 4-position. The presence of these functional groups imparts unique chemical and physical properties to the molecule. The dichlorophenyl substituent contributes to the compound's lipophilicity, which can enhance its ability to cross biological membranes and reach target sites within cells. The amino group at the 4-position provides a site for further functionalization, making it a valuable scaffold for drug design and development.

Synthesis Methods

The synthesis of 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine can be achieved through various routes, each with its own advantages and limitations. One common method involves the reaction of 3,4-dichloroacetophenone with hydrazine hydrate to form the corresponding hydrazone intermediate. This intermediate is then cyclized using an appropriate base to yield the desired pyrazole derivative. Another approach involves the reaction of 3,4-dichlorobenzoyl chloride with hydrazine hydrate followed by cyclization under suitable conditions.

Recent advancements in synthetic methodologies have focused on improving the efficiency and selectivity of these reactions. For example, the use of microwave-assisted synthesis has been shown to significantly reduce reaction times and improve yields. Additionally, green chemistry principles have been applied to develop more environmentally friendly synthetic routes that minimize waste and reduce energy consumption.

Biological Activities

1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine has been extensively studied for its potential therapeutic applications due to its diverse biological activities. One of the most notable properties of this compound is its anti-inflammatory activity. Research has shown that it can inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in vitro. This makes it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine has also demonstrated antiviral activity against several viral strains. Studies have shown that it can inhibit the replication of viruses such as influenza A virus and herpes simplex virus (HSV). The mechanism of action is believed to involve interference with viral entry or replication processes within host cells.

Cancer Research

The anticancer potential of 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine has been a focus of recent research efforts. Preclinical studies have shown that it can induce apoptosis in various cancer cell lines, including those derived from breast cancer, lung cancer, and colon cancer. The compound appears to target multiple signaling pathways involved in cell proliferation and survival, making it a promising lead compound for further drug development.

Clinical Trials and Future Directions

While much of the research on 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine has been conducted in preclinical settings, there is growing interest in advancing this compound into clinical trials. Several pharmaceutical companies are currently investigating its potential as a therapeutic agent for various diseases. Clinical trials are expected to provide valuable insights into its safety profile and efficacy in human subjects.

In conclusion, 1-(3,4-Dichlorophenyl)-1H-pyrazol-4-amine (CAS No. 1153040-15-3) is a promising compound with a wide range of potential therapeutic applications. Its unique chemical structure and diverse biological activities make it an attractive candidate for further research and development in medicinal chemistry. As more studies are conducted and clinical trials progress, we can expect to gain a deeper understanding of its full therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)